The number of CD8+T cells has implication for chemotherapy, and immunotherapy could improve the therapeutic effects of tumor treatment; it has been confirmed in patients with gastric cancer, breast cancer, and melanoma [47–49]. Here, CD8A is linked to neoplasm.